These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Allergic and nonallergic delayed infusion reactions during natalizumab therapy. Hellwig K; Schimrigk S; Fischer M; Haghikia A; Müller T; Chan A; Gold R Arch Neurol; 2008 May; 65(5):656-8. PubMed ID: 18474743 [TBL] [Abstract][Full Text] [Related]
23. Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis. Rinaldi F; Perini P; Calabrese M; Rinaldi L; Gallo P Mult Scler; 2009 Nov; 15(11):1359-62. PubMed ID: 19812116 [TBL] [Abstract][Full Text] [Related]
24. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296 [TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229 [TBL] [Abstract][Full Text] [Related]
26. 'Time is brain' also in multiple sclerosis. Freedman MS Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740 [No Abstract] [Full Text] [Related]
27. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228 [TBL] [Abstract][Full Text] [Related]
28. The diagnosis of MS: white spots and red flags. Ratchford JN; Calabresi PA Neurology; 2008 Mar; 70(13 Pt 2):1071-2. PubMed ID: 18362269 [No Abstract] [Full Text] [Related]
29. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Lassmann H Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402 [TBL] [Abstract][Full Text] [Related]
30. The role of natalizumab in the treatment of multiple sclerosis. Coyle PK Am J Manag Care; 2010 Jun; 16(6 Suppl):S164-70. PubMed ID: 20615052 [TBL] [Abstract][Full Text] [Related]
31. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Cabrera-Gómez JA; Quevedo-Sotolongo L; González-Quevedo A; Lima S; Real-González Y; Cristófol-Corominas M; Romero-García K; Ugarte-Sánchez C; Jordán-González J; de la Nuez JE; Lahera JG; Tellez R; Pedroso-Ibañez I; Roca RR; Cabrera-Núñez AY Mult Scler; 2007 Mar; 13(2):186-92. PubMed ID: 17439883 [TBL] [Abstract][Full Text] [Related]
33. Natalizumab in the treatment of pediatric multiple sclerosis. Talab R; Talabova M; Klzo L Neuro Endocrinol Lett; 2012; 33(6):579-89. PubMed ID: 23160229 [TBL] [Abstract][Full Text] [Related]
34. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Moraal B; van den Elskamp IJ; Knol DL; Uitdehaag BM; Geurts JJ; Vrenken H; Pouwels PJ; van Schijndel RA; Meier DS; Guttmann CR; Barkhof F Ann Neurol; 2010 May; 67(5):667-75. PubMed ID: 20437564 [TBL] [Abstract][Full Text] [Related]
36. A case of MS presenting with SUNCT status. Bogorad I; Blum S; Green M Headache; 2010 Jan; 50(1):141-3. PubMed ID: 19751367 [No Abstract] [Full Text] [Related]
37. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Balcer LJ; Galetta SL; Calabresi PA; Confavreux C; Giovannoni G; Havrdova E; Hutchinson M; Kappos L; Lublin FD; Miller DH; O'Connor PW; Phillips JT; Polman CH; Radue EW; Rudick RA; Stuart WH; Wajgt A; Weinstock-Guttman B; Wynn DR; Lynn F; Panzara MA Neurology; 2007 Apr; 68(16):1299-304. PubMed ID: 17438220 [TBL] [Abstract][Full Text] [Related]
38. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. van den Elskamp IJ; Knol DL; Vrenken H; Karas G; Meijerman A; Filippi M; Kappos L; Fazekas F; Wagner K; Pohl C; Sandbrink R; Polman CH; Uitdehaag BM; Barkhof F Mult Scler; 2010 Jun; 16(6):660-9. PubMed ID: 20350960 [TBL] [Abstract][Full Text] [Related]